Loading decisions…
Loading decisions…
16,110 vetted Board decisions for Prostate cancer.
The Veteran's prostate condition, including prostate cancer, prostatitis, and benign prostatic hyperplasia, is remanded for further examination and opinion regarding the relationship to service, particularly exposure to Agent Orange.
The Veteran's service connection claims for coronary heart disease, prostate cancer, and bladder cancer are granted as these conditions are presumed related to herbicide exposure during his active military service in Thailand.
The Veteran's service-connected disabilities render him unable to secure and follow a substantially gainful occupation, warranting a TDIU based on PTSD and prostate cancer.
The Board has granted service connection for prostate cancer, coronary atherosclerosis and paroxysmal atrial fibrillation, diabetes mellitus type II, and erectile dysfunction due to in-service exposure to herbicide agents. Bone cancer is denied as there was no diagnosis of multiple myeloma or other presumptively service-connected condition.
The Veteran's prostate cancer is granted service connection as presumptively linked to herbicide exposure during his service at U-Tapao Royal Thai Air Force Base in Thailand.
The Veteran's bladder and prostate cancers are granted service connection due to exposure to herbicide agents during his time in Thailand, as provided by the PACT Act of 2022.
The Veteran's cause of death, adult failure to thrive due to or as a consequence of prostate cancer, was not service-connected. The Board found no evidence linking the conditions to his military service.
The Board denied the Veteran's request for an earlier effective date for service connection of prostate cancer and diabetes mellitus, type II. The decision on prostate cancer was based on March 27, 2020 as the date VA received the intent to file a claim, which was followed up within one year with a formalized claim.
The Veteran's claims for service connection are remanded due to incomplete records, particularly regarding his periods of active duty and inactive duty training. The Board requires additional development to account for any missing records.
The Veteran's death was not caused by a service-connected disability, and the cause of death (malignant neoplasm of bladder) is not related to his military service.
The Veteran's prostate cancer residuals and voiding dysfunction are rated at 20% effective March 1, 2018. The Veteran's prostatectomy scar is rated at 10% effective March 1, 2018.
The Board has remanded the claims for prostate cancer and frontotemporal brain tumor due to ionizing radiation exposure, as no dose estimate could be obtained from available records. The Veteran's Radiation Risk Activity worksheet, service medical records, and hearing testimony were reviewed but not sufficient to determine if he was exposed.
The Veteran's claim for an effective date prior to August 4, 2014, for the award of special monthly compensation (SMC) based on the need for aid and attendance was denied. The Board found that it was not factually ascertainable prior to August 4, 2014, that the Veteran met the criteria for SMC.
The Veteran's service-connected prostate cancer residuals and coronary artery disease have rendered him unable to secure or follow substantially gainful employment from April 1, 2011 to March 20, 2014.
The Veteran's service connection claim for prostate cancer as due to herbicide agent exposure is granted, with the presumption of exposure based on his service in Guam under the PACT Act.
The Veteran's prostate cancer is presumed to have been caused by exposure to herbicide agents during his service aboard the U.S.S. Midway, and thus he is granted service connection.
The Veteran's pulmonary fibrosis, prostate cancer, and lymphatic cancer are currently service-connected. However, the VA needs to provide medical opinions regarding whether these conditions are related to his active duty service or exposure to chemicals as an air policeman on the flight line.
The Veteran's prostate cancer is granted as service connected due to exposure during his time in Thailand, which falls under the PACT Act presumption.
The Veteran's prostate cancer is granted as service connected due to exposure during his service in Thailand, which falls under the PACT Act presumption.
The Board denied the Veteran's claims for service connection for diabetes mellitus, prostate cancer, and coronary artery disease, including as due to in-service exposure to an herbicide agent. The evidence did not support finding that his active service unit was among those units presumed exposed to an herbicide agent.
← Back to Prostate cancer overview
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.